UniProt ID | PDCD4_HUMAN | |
---|---|---|
UniProt AC | Q53EL6 | |
Protein Name | Programmed cell death protein 4 | |
Gene Name | PDCD4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 469 | |
Subcellular Localization | Nucleus . Cytoplasm . Shuttles between the nucleus and cytoplasm (By similarity). Predominantly nuclear under normal growth conditions, and when phosphorylated at Ser-457 (PubMed:16357133). | |
Protein Description | Inhibits translation initiation and cap-dependent translation. May excert its function by hindering the interaction between EIF4A1 and EIF4G. Inhibits the helicase activity of EIF4A. Modulates the activation of JUN kinase. Down-regulates the expression of MAP4K1, thus inhibiting events important in driving invasion, namely, MAPK85 activation and consequent JUN-dependent transcription. May play a role in apoptosis. Tumor suppressor. Inhibits tumor promoter-induced neoplastic transformation. Binds RNA (By similarity).. | |
Protein Sequence | MDVENEQILNVNPADPDNLSDSLFSGDEENAGTEEIKNEINGNWISASSINEARINAKAKRRLRKNSSRDSGRGDSVSDSGSDALRSGLTVPTSPKGRLLDRRSRSGKGRGLPKKGGAGGKGVWGTPGQVYDVEEVDVKDPNYDDDQENCVYETVVLPLDERAFEKTLTPIIQEYFEHGDTNEVAEMLRDLNLGEMKSGVPVLAVSLALEGKASHREMTSKLLSDLCGTVMSTTDVEKSFDKLLKDLPELALDTPRAPQLVGQFIARAVGDGILCNTYIDSYKGTVDCVQARAALDKATVLLSMSKGGKRKDSVWGSGGGQQSVNHLVKEIDMLLKEYLLSGDISEAEHCLKELEVPHFHHELVYEAIIMVLESTGESTFKMILDLLKSLWKSSTITVDQMKRGYERIYNEIPDINLDVPHSYSVLERFVEECFQAGIISKQLRDLCPSRGRKRFVSEGDGGRLKPESY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MDVENEQI -------CCCCCCCC | 13.54 | 20068231 | |
2 (in isoform 2) | Phosphorylation | - | 57.34 | 28348404 | |
4 (in isoform 2) | Phosphorylation | - | 51.27 | 28348404 | |
14 | Phosphorylation | QILNVNPADPDNLSD CCCCCCCCCCCCCCC | 35.45 | 27251275 | |
14 (in isoform 2) | Phosphorylation | - | 35.45 | 28348404 | |
20 | Phosphorylation | PADPDNLSDSLFSGD CCCCCCCCCCCCCCC | 31.26 | 20363803 | |
22 | Phosphorylation | DPDNLSDSLFSGDEE CCCCCCCCCCCCCCC | 28.12 | 20068231 | |
22 (in isoform 2) | Phosphorylation | - | 28.12 | 27174698 | |
25 | Phosphorylation | NLSDSLFSGDEENAG CCCCCCCCCCCCCCC | 51.10 | 20363803 | |
46 | Phosphorylation | EINGNWISASSINEA HHCCCEECHHHHCHH | 17.45 | 25159151 | |
48 | Phosphorylation | NGNWISASSINEARI CCCEECHHHHCHHHH | 25.59 | 20068231 | |
49 | Phosphorylation | GNWISASSINEARIN CCEECHHHHCHHHHH | 29.20 | 20068231 | |
58 | Ubiquitination | NEARINAKAKRRLRK CHHHHHHHHHHHHHH | 50.37 | - | |
60 | Ubiquitination | ARINAKAKRRLRKNS HHHHHHHHHHHHHCC | 37.03 | - | |
67 | Phosphorylation | KRRLRKNSSRDSGRG HHHHHHCCCCCCCCC | 29.77 | 23401153 | |
68 | Phosphorylation | RRLRKNSSRDSGRGD HHHHHCCCCCCCCCC | 49.88 | 27273156 | |
71 | Phosphorylation | RKNSSRDSGRGDSVS HHCCCCCCCCCCCCC | 29.31 | 25159151 | |
73 | Methylation | NSSRDSGRGDSVSDS CCCCCCCCCCCCCCC | 50.09 | 115386825 | |
76 | Phosphorylation | RDSGRGDSVSDSGSD CCCCCCCCCCCCCHH | 26.75 | 29255136 | |
78 | Phosphorylation | SGRGDSVSDSGSDAL CCCCCCCCCCCHHHH | 29.97 | 29255136 | |
80 | Phosphorylation | RGDSVSDSGSDALRS CCCCCCCCCHHHHHC | 32.46 | 29255136 | |
82 | Phosphorylation | DSVSDSGSDALRSGL CCCCCCCHHHHHCCC | 24.54 | 27273156 | |
87 | Phosphorylation | SGSDALRSGLTVPTS CCHHHHHCCCCCCCC | 38.72 | 23927012 | |
90 | Phosphorylation | DALRSGLTVPTSPKG HHHHCCCCCCCCCCC | 28.15 | 23927012 | |
93 | Phosphorylation | RSGLTVPTSPKGRLL HCCCCCCCCCCCCCC | 54.01 | 29255136 | |
94 | Phosphorylation | SGLTVPTSPKGRLLD CCCCCCCCCCCCCCC | 20.67 | 19664994 | |
96 | Ubiquitination | LTVPTSPKGRLLDRR CCCCCCCCCCCCCCC | 57.33 | - | |
121 | Ubiquitination | KKGGAGGKGVWGTPG CCCCCCCCCCCCCCC | 49.74 | - | |
126 | Phosphorylation | GGKGVWGTPGQVYDV CCCCCCCCCCCEEEE | 14.45 | 21815630 | |
131 | Phosphorylation | WGTPGQVYDVEEVDV CCCCCCEEEEEEECC | 13.34 | 22210691 | |
143 | Phosphorylation | VDVKDPNYDDDQENC ECCCCCCCCCCCCCC | 26.57 | 22817900 | |
152 | Phosphorylation | DDQENCVYETVVLPL CCCCCCEEEEEEEEC | 14.21 | 25159151 | |
166 | Ubiquitination | LDERAFEKTLTPIIQ CCHHHHHHHCHHHHH | 42.24 | 21906983 | |
175 | Phosphorylation | LTPIIQEYFEHGDTN CHHHHHHHHHCCCHH | 9.63 | 27642862 | |
197 | Ubiquitination | DLNLGEMKSGVPVLA HCCCCCCCCCCCEEE | 39.49 | - | |
212 | Ubiquitination | VSLALEGKASHREMT HHHHHCCCHHHHHHH | 37.02 | - | |
224 | Phosphorylation | EMTSKLLSDLCGTVM HHHHHHHHHHHCCHH | 38.69 | 29449344 | |
229 | Phosphorylation | LLSDLCGTVMSTTDV HHHHHHCCHHCCHHH | 16.43 | 29449344 | |
231 | Ubiquitination | SDLCGTVMSTTDVEK HHHHCCHHCCHHHHH | 2.71 | 21890473 | |
232 | Phosphorylation | DLCGTVMSTTDVEKS HHHCCHHCCHHHHHH | 24.66 | 29449344 | |
233 | Phosphorylation | LCGTVMSTTDVEKSF HHCCHHCCHHHHHHH | 14.66 | 29449344 | |
234 | Phosphorylation | CGTVMSTTDVEKSFD HCCHHCCHHHHHHHH | 30.64 | 29449344 | |
238 | Ubiquitination | MSTTDVEKSFDKLLK HCCHHHHHHHHHHHH | 57.16 | - | |
239 | Phosphorylation | STTDVEKSFDKLLKD CCHHHHHHHHHHHHH | 25.77 | 29449344 | |
242 | Ubiquitination | DVEKSFDKLLKDLPE HHHHHHHHHHHHCHH | 54.42 | 21890473 | |
242 | Ubiquitination | DVEKSFDKLLKDLPE HHHHHHHHHHHHCHH | 54.42 | 21890473 | |
245 | Ubiquitination | KSFDKLLKDLPELAL HHHHHHHHHCHHHHC | 68.60 | 21906983 | |
254 | Phosphorylation | LPELALDTPRAPQLV CHHHHCCCCCHHHHH | 18.61 | - | |
267 | Methylation | LVGQFIARAVGDGIL HHHHHHHHHHCCCEE | 25.62 | 115486721 | |
283 | Ubiquitination | NTYIDSYKGTVDCVQ CEEECCCCCCHHHHH | 52.65 | 2190698 | |
297 | Acetylation | QARAALDKATVLLSM HHHHHHHHHHHEEEC | 46.97 | 25953088 | |
297 | Ubiquitination | QARAALDKATVLLSM HHHHHHHHHHHEEEC | 46.97 | - | |
299 | Phosphorylation | RAALDKATVLLSMSK HHHHHHHHHEEECCC | 19.89 | 20068231 | |
303 | Phosphorylation | DKATVLLSMSKGGKR HHHHHEEECCCCCCC | 19.49 | 20068231 | |
305 | Phosphorylation | ATVLLSMSKGGKRKD HHHEEECCCCCCCCC | 25.44 | 27251275 | |
306 | Acetylation | TVLLSMSKGGKRKDS HHEEECCCCCCCCCC | 64.14 | 25953088 | |
306 | Ubiquitination | TVLLSMSKGGKRKDS HHEEECCCCCCCCCC | 64.14 | - | |
311 | Ubiquitination | MSKGGKRKDSVWGSG CCCCCCCCCCCCCCC | 58.82 | - | |
313 | Phosphorylation | KGGKRKDSVWGSGGG CCCCCCCCCCCCCCH | 23.86 | 20044836 | |
317 | Phosphorylation | RKDSVWGSGGGQQSV CCCCCCCCCCHHHHH | 20.67 | 23401153 | |
323 | Phosphorylation | GSGGGQQSVNHLVKE CCCCHHHHHHHHHHH | 19.59 | 23401153 | |
333 | Sulfoxidation | HLVKEIDMLLKEYLL HHHHHHHHHHHHHHH | 6.08 | 21406390 | |
345 | Phosphorylation | YLLSGDISEAEHCLK HHHHCCHHHHHHHHH | 35.18 | 25159151 | |
392 | Ubiquitination | DLLKSLWKSSTITVD HHHHHHHHCCCCCHH | 39.56 | - | |
393 | Phosphorylation | LLKSLWKSSTITVDQ HHHHHHHCCCCCHHH | 22.57 | 20068231 | |
394 | Phosphorylation | LKSLWKSSTITVDQM HHHHHHCCCCCHHHH | 21.80 | 20068231 | |
395 | Phosphorylation | KSLWKSSTITVDQMK HHHHHCCCCCHHHHH | 27.97 | 20068231 | |
397 | Phosphorylation | LWKSSTITVDQMKRG HHHCCCCCHHHHHHH | 20.37 | 20068231 | |
402 | Ubiquitination | TITVDQMKRGYERIY CCCHHHHHHHHHHHH | 36.72 | - | |
402 | 2-Hydroxyisobutyrylation | TITVDQMKRGYERIY CCCHHHHHHHHHHHH | 36.72 | - | |
405 | Phosphorylation | VDQMKRGYERIYNEI HHHHHHHHHHHHHHC | 13.18 | 22817900 | |
440 | Phosphorylation | CFQAGIISKQLRDLC HHHHCHHHHHHHHHC | 16.66 | 24719451 | |
457 | Phosphorylation | RGRKRFVSEGDGGRL CCCCCCCCCCCCCCC | 32.90 | 29255136 | |
465 | Sumoylation | EGDGGRLKPESY--- CCCCCCCCCCCC--- | 45.43 | - | |
465 | Sumoylation | EGDGGRLKPESY--- CCCCCCCCCCCC--- | 45.43 | - | |
468 | Phosphorylation | GGRLKPESY------ CCCCCCCCC------ | 44.67 | 21815630 | |
469 | Phosphorylation | GRLKPESY------- CCCCCCCC------- | 22.40 | 23186163 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
67 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
67 | S | Phosphorylation | Kinase | P70S6K | P23443 | PSP |
67 | S | Phosphorylation | Kinase | AKT-FAMILY | - | GPS |
67 | S | Phosphorylation | Kinase | PKB_GROUP | - | PhosphoELM |
76 | S | Phosphorylation | Kinase | RPS6KA1 | Q15418 | GPS |
457 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
457 | S | Phosphorylation | Kinase | RPS6KA1 | Q15418 | GPS |
457 | S | Phosphorylation | Kinase | P70S6K | P23443 | PSP |
457 | S | Phosphorylation | Kinase | AKT-FAMILY | - | GPS |
457 | S | Phosphorylation | Kinase | PKB_GROUP | - | PhosphoELM |
- | K | Ubiquitination | E3 ubiquitin ligase | BTRC | Q9Y297 | PMID:17053147 |
- | K | Ubiquitination | E3 ubiquitin ligase | FBXW11 | Q9UKB1 | PMID:24658274 |
- | K | Ubiquitination | E3 ubiquitin ligase | SKP2 | Q13309 | PMID:30760284 |
- | K | Ubiquitination | E3 ubiquitin ligase | DTL | Q9NZJ0 | PMID:31409387 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
67 | S | Phosphorylation |
| 16357133 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PDCD4_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RL5_HUMAN | RPL5 | physical | 12054647 | |
RS13_HUMAN | RPS13 | physical | 12054647 | |
IF4G1_HUMAN | EIF4G1 | physical | 12054647 | |
FBW1A_HUMAN | BTRC | physical | 18296647 | |
FBW1A_HUMAN | BTRC | physical | 17053147 | |
FBW1A_HUMAN | BTRC | physical | 23056346 | |
DAXX_HUMAN | DAXX | physical | 23536002 | |
ARC1B_HUMAN | ARPC1B | physical | 22863883 | |
BTF3_HUMAN | BTF3 | physical | 22863883 | |
PAIP1_HUMAN | PAIP1 | physical | 22863883 | |
TPD52_HUMAN | TPD52 | physical | 22863883 | |
UFD1_HUMAN | UFD1L | physical | 22863883 | |
IF4A2_HUMAN | EIF4A2 | physical | 26344197 | |
IF6_HUMAN | EIF6 | physical | 26344197 | |
ERF1_HUMAN | ETF1 | physical | 26344197 | |
CNDD3_HUMAN | NCAPD3 | physical | 26344197 | |
PCF11_HUMAN | PCF11 | physical | 26344197 | |
PRS4_HUMAN | PSMC1 | physical | 26344197 | |
SMD1_HUMAN | SNRPD1 | physical | 26344197 | |
UBE2S_HUMAN | UBE2S | physical | 25928036 | |
IBTK_HUMAN | IBTK | physical | 25882842 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-94, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-78 AND SER-94, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76; SER-78; SER-80;SER-94 AND SER-457, AND MASS SPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-93; SER-94 AND SER-457,AND MASS SPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-457, AND MASSSPECTROMETRY. | |
"S6K1- and betaTRCP-mediated degradation of PDCD4 promotes proteintranslation and cell growth."; Dorrello N.V., Peschiaroli A., Guardavaccaro D., Colburn N.H.,Sherman N.E., Pagano M.; Science 314:467-471(2006). Cited for: FUNCTION, PHOSPHORYLATION AT SER-67 BY RPS6KB1, PHOSPHODEGRON MOTIF,INTERACTION WITH BTRC AND FBXW11, UBIQUITINATION, MASS SPECTROMETRY,AND MUTAGENESIS OF SER-67; SER-71 AND SER-76. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-93 AND SER-457, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76 AND SER-457, AND MASSSPECTROMETRY. | |
"Akt phosphorylates and regulates Pdcd4 tumor suppressor protein."; Palamarchuk A., Efanov A., Maximov V., Aqeilan R.I., Croce C.M.,Pekarsky Y.; Cancer Res. 65:11282-11286(2005). Cited for: PHOSPHORYLATION AT SER-67 AND SER-457 BY PKB, FUNCTION, MUTAGENESIS OFSER-67 AND SER-457, AND SUBCELLULAR LOCATION. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-152, AND MASSSPECTROMETRY. |